Inventiva - ADR

NASDAQ:IVA  
15.25
+0.61 (+4.17%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)626.62M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.45 Million
Adjusted EPS-$0.82
See more estimates
10-Day MA$14.66
50-Day MA$14.14
200-Day MA$13.81
See more pivots

Inventiva - ADR Stock, NASDAQ:IVA

50, rue de Dijon, Daix, Bourgogne-Franche-Comte 21121
France
Phone: +33.3.80.44.75.00
Number of Employees: 94

Description

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Fr?©d?©ric Cren on October 27, 2011 and is headquartered in Daix, France.